rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2010-8-27
|
pubmed:abstractText |
Endometrial hyperplasia without cytological atypia is commonly treated with progestins, but other treatment regimes may be available with equivalent efficacy and low side effects.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, Synthetic,
http://linkedlifedata.com/resource/pubmed/chemical/Genistein,
http://linkedlifedata.com/resource/pubmed/chemical/Norethindrone,
http://linkedlifedata.com/resource/pubmed/chemical/Phytoestrogens,
http://linkedlifedata.com/resource/pubmed/chemical/Plant Extracts,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/norethindrone acetate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1618-095X
|
pubmed:author |
pubmed-author:AdamoElena BiancaEB,
pubmed-author:AltavillaDomenicaD,
pubmed-author:BittoAlessandraA,
pubmed-author:D'AnnaRosarioR,
pubmed-author:GiordanoDomenicoD,
pubmed-author:GraneseRobertaR,
pubmed-author:MaisanoDanieleD,
pubmed-author:MariniHerbertH,
pubmed-author:NicotinaPiero AntonioPA,
pubmed-author:SquadritoFrancescoF,
pubmed-author:TrioloOnofrioO,
pubmed-author:VillariDanielaD
|
pubmed:copyrightInfo |
Copyright 2010 Elsevier GmbH. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
844-50
|
pubmed:meshHeading |
pubmed-meshheading:20570122-Adult,
pubmed-meshheading:20570122-Contraceptives, Oral, Synthetic,
pubmed-meshheading:20570122-Double-Blind Method,
pubmed-meshheading:20570122-Endometrial Hyperplasia,
pubmed-meshheading:20570122-Endometrium,
pubmed-meshheading:20570122-Female,
pubmed-meshheading:20570122-Genistein,
pubmed-meshheading:20570122-Humans,
pubmed-meshheading:20570122-Middle Aged,
pubmed-meshheading:20570122-Norethindrone,
pubmed-meshheading:20570122-Phytoestrogens,
pubmed-meshheading:20570122-Phytotherapy,
pubmed-meshheading:20570122-Plant Extracts,
pubmed-meshheading:20570122-Premenopause,
pubmed-meshheading:20570122-Receptors, Estrogen,
pubmed-meshheading:20570122-Receptors, Progesterone,
pubmed-meshheading:20570122-Uterine Hemorrhage
|
pubmed:year |
2010
|
pubmed:articleTitle |
Genistein aglycone: a new therapeutic approach to reduce endometrial hyperplasia.
|
pubmed:affiliation |
Department of Clinical and Experimental Medicine and Pharmacology, c/o AOU Policlinico G. Martino, Gazzi, Messina, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|